[A new approach to the evaluation of the effectiveness of antihypertensive therapy in patients with mild and moderate arterial hypertension based on the example of isoptin retard].
Isoptin-retard (Knoll, BASF) in a single dose 240 mg/day provides a significant hypotensive effect in patients with mild and moderate essential hypertension noticeable as early as treatment day 2. Sensitivity to the drug does not tend to decrease with time. The treatment should be conducted under ECG monitoring.
G G
GG
Arabidze
V V
VV
Dmitriev
A N
AN
Rogoza
D001794:Blood Pressure / Q000187:drug effects; D003692:Delayed-Action Preparations; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014700:Verapamil / Q000008:administration & dosage* / Q000494:pharmacology
D003692:Delayed-Action Preparations; D014700:Verapamil
Novyĭ podkhod k otsenke éffektivnosti gipotenzivnoĭ terapii u bol'nykh miagkoĭ i umerennoĭ arterial'noĭ gipertonieĭ na primere primeneniia izoptina-retarda.